Your browser doesn't support javascript.
loading
Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor.
Gerrits, A J; Jakubowski, J A; Sugidachi, A; Michelson, A D; Frelinger, A L.
Affiliation
  • Gerrits AJ; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Jakubowski JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Sugidachi A; Biological Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Michelson AD; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Frelinger AL; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
J Thromb Haemost ; 15(5): 858-867, 2017 05.
Article in En | MEDLINE | ID: mdl-28092426
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Platelet Aggregation Inhibitors / Adenosine / Platelet Aggregation / Purinergic P2Y Receptor Antagonists Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Platelet Aggregation Inhibitors / Adenosine / Platelet Aggregation / Purinergic P2Y Receptor Antagonists Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Estados Unidos